Medicare Patient Outcomes for Methadone and Buprenorphine Treatment

A 9.5 KB Excel file contains tabular data for a target trial emulation comparing methadone and buprenorphine outcomes among Medicare patients. The dataset, authored by Yu-Jung Jenny Wei and last updated in March 2026, is licensed under CC BY 4.0. Row and column counts are unspecified.

Use Cases

• Compare patient outcome metrics between the methadone and buprenorphine treatment groups specified in the trial emulation.
• Analyze treatment patterns for Opioid Use Disorder within the United States Medicare patient population.
• Validate the target trial design methodology using the provided specification and emulation data structure.

Strengths

• Data is recent, with a last update timestamp of March 26, 2026.
• Clear focus on a specific clinical comparison (methadone vs. buprenorphine) within a defined population (Medicare patients).
• Published under a permissive CC BY 4.0 license for reuse and sharing.

Limitations

• The dataset is very small at 9.5 KB, indicating limited scope and likely a small number of observations or summary-level data.
• Lacks metadata on rows, columns, and sample data, hindering assessment of structure and analytical potential.
• Geographic coverage is limited to the United States, and temporal coverage is unspecified.

Provenance

Source

figshare, authored by Yu-Jung Jenny Wei.

Collection Method

Specification and emulation of a target trial; exact data gathering method is null.

Time Range

null

Freshness

Last updated 2026-03-26.

Geography

United States